The "Defending American Sovereignty in Global Pandemics Act" suspends U.S. funding for the World Health Organization (WHO) until any pandemic treaty is approved by the Senate with a two-thirds vote. This ensures Senate approval for international agreements related to pandemic response under the WHO.
John Barrasso
Senator
WY
The "Defending American Sovereignty in Global Pandemics Act" suspends U.S. funding to the World Health Organization (WHO) until any pandemic-related treaty is ratified by a two-thirds vote in the Senate. It restricts U.S. participation in international agreements under the WHO Constitution for pandemic response unless approved as a treaty by the Senate. The Act prohibits U.S. funds from being used for the WHO from the date any such agreement goes into effect until Senate approval.
The "Defending American Sovereignty in Global Pandemics Act" puts a temporary hold on U.S. funding to the World Health Organization (WHO). The freeze kicks in the moment any international agreement on pandemic response (referred to here as a "pandemic treaty") comes into effect. The funding stays locked down until the Senate approves that agreement as a formal treaty, which requires a two-thirds majority vote (SEC. 2).
This bill, introduced by Senator Barrasso, makes it clear: no money flows from the U.S. to the WHO if there's a pandemic agreement in place that hasn't jumped through the Senate's treaty hoop. This aims to directly impact how international pandemic responses are handled, potentially reshaping collaborative efforts. For example, if a global initiative is launched to stockpile vaccines or coordinate research, the U.S.'s participation (and funding) hinges entirely on Senate approval.
Let's say you own a small business that relies on international supply chains. A coordinated global response to a new pandemic could be the difference between staying afloat and shutting down. This bill adds a layer of uncertainty. Will the Senate swiftly approve an agreement, allowing U.S. participation and potentially stabilizing global markets? Or will it get bogged down in debate, leaving businesses – and the global economy – in limbo? This is not just about health; it's about economic stability, too.
While the bill champions American sovereignty, it could also create friction in international relations. Imagine a scenario where a new virus emerges, and rapid global cooperation is crucial. The funding freeze could delay the U.S.'s ability to participate fully, potentially impacting the speed and effectiveness of the response, and potentially put the health of U.S. citizens at risk. It also raises questions about the definition of "pandemic treaty." Could this be interpreted broadly, encompassing a wide range of agreements and further limiting international collaboration? The bill's language leaves room for interpretation, which could lead to future disputes. The requirement that any agreement related to pandemic response be treated as a treaty is a high bar, potentially slowing down responses to fast-moving threats.